¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ ¹× »ê¾÷ ºÐ¼® º¸°í¼ : ¾à¹° À¯Çüº°, Á¦Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Oxycodone Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Short-acting, Long-acting); By Dosage Form; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
»óǰÄÚµå
:
1424093
¸®¼Ä¡»ç
:
Polaris Market Research
¹ßÇàÀÏ
:
2024³â 01¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 118 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 82¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
¾Ï, ·ù¸¶Æ¼½º °üÀý¿°, ¿äÅë, ¼¶À¯±ÙÀ°Åë µî ¸¸¼º ÅëÁõ ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ¿Á½ÃÄÚµ· ½ÃÀå È®´ëÀÇ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ, ¿Á½ÃÄÚµ·Àº ´Ù¸¥ ¾à¹°ÀÌ º¸¿©ÁÖÁö ¸øÇÏ´Â ÁßÁõ ÅëÁõ °ü¸®¿¡ ´ëÇÑ ¹ÝÀÀ¼ºÀÌ ¿Á½ÃÄÚµ· ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ¾à¹°ÀÇ À¯¸ÁÇÑ °á°ú¿Í ¼¹æÇü ¿Á½ÃÄÚµ· ÀǾàǰ°ú °ü·ÃµÈ ÀåÁ¡À¸·Î ÀÎÇØ 󹿷®ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿Á½ÃÄÚµ· ÀǾàǰÀÇ ¿ì¼öÇÑ ¼øÀÀµµ¿Í ªÀº Åõ¿© °£°ÝÀ¸·Î ÀÎÇÑ ÆíÀǼºÀº ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¶ÇÇÑ, ¼¹æÇü ĸ½¶ÀÇ µîÀå°ú ¼ºÀÎÀÇ ±Ø½ÉÇÑ ÅëÁõÀÇ ³ôÀº À¯º´·üµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÀå ÁøÃâ±â¾÷µéÀÌ º¸À¯ÇÑ Æ¯Çã¿Í ¸¶ÄÉÆÃ ¹× È«º¸¿¡ ´ëÇÑ ºñ¿ë Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ÄÚ·¹Áö¿ò ÆÄ¸¶½´Æ¼ÄÃÀÇ Xtampza ERÀº 2036³â±îÁö ƯÇã º¸È£¸¦ ¹Þ°í ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ¿Á½ÃÄÚµ· Á¦Á¦°¡ ´Ù¸¥ ¿ÀÇÇ¿ÀÀ̵å Á¦Á¦º¸´Ù À¯¸ÁÇÑ °á°ú¸¦ º¸À̰í ÀÖ´Ù´Â Á¡µµ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¹æÇü Á¦Á¦¿Í °°Àº ¾à¹° Àü´Þ ½Ã½ºÅÛÀÇ ¹ßÀü°ú ÇÔ²² »õ·Î¿î ¾à¹°ÀÇ ÃâÇöÀº ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀåÀÇ ¼ºÀå¿¡ Àå±âÀûÀÎ ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¼ö¼ú ÈÄ ±Ø½ÉÇÑ ÅëÁõÀ» ¿ÏÈÇÏ´Â ¿Á½ÃÄÚµ·ÀÇ ´É·ÂÀº ¼ö¼ú Áõ°¡¿Í ÇÔ²² ½ÃÀå È®´ë¸¦ Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿Á½ÃÄÚµ·ÀÌ ÅëÁõ ¿ÏÈ ¾à¹°·Î ³Î¸® ¹Þ¾Æµé¿©Áö°í ÀÖÀ¸¸ç, ¼ö¼ú ÈÄ ÅëÁõ °ü¸®¸¦ À§ÇØ ¿Á½ÃÄÚµ·¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì°³Ã´ ½ÃÀå¿¡¼ÀÇ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀο¡ ´ëÇÑ ±â¾÷µéÀÇ ³ôÀº °ü½Éµµ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ, ¿îµ¿ ºÎÁ·, ´ã¹è »ç¿ë, ºñ¸¸Àº ¸¸¼º ÅëÁõÀ¸·Î °íÅë¹Þ´Â ȯÀÚ ¼ö¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°èºñ¸¸¿¬¸ÍÀÇ World Obesity Atlas 2023 Report¿¡ µû¸£¸é, Àü ¼¼°è °úüÁß ¶Ç´Â ºñ¸¸ Àα¸´Â 2020³â 26¾ï ¸í¿¡¼ 40¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºñ¸¸ Àα¸´Â ÅëÁõ °ü¸® ¾à¹°À» ÇÊ¿ä·Î ÇÏ´Â »ç¶÷µéÀÌ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
ÅëÁõ °ü¸®¸¦ °³¼±Çϰí ÅëÁõ °µµÀÇ ÆíÂ÷¸¦ ÁÙÀÏ ¼ö ÀÖ´Ù´Â ÀåÁ¡À¸·Î ÀÎÇØ Àå½Ã°£ ÀÛ¿ëÇü ºÎ¹®ÀÌ ½ÃÀåÀ» Àå¾ÇÇϰí ÀÖ½À´Ï´Ù.
¼¹æÇü ĸ½¶ÀÇ ÃâÇöÀ¸·Î ĸ½¶Á¦ ºÎ¹®Àº °¡Àå ³ôÀº CAGR·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º´¿ø ºÐ¾ß´Â ¼ö¼ú Áõ°¡¿Í ÀÔ¿ø ȯÀÚ Áõ°¡·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.
ºÏ¹Ì´Â ¿Á½ÃÄÚµ· 󹿷®ÀÌ ¸¹°í ¸¸¼º ÅëÁõ ÁúȯÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ¼¼°èÀÇ ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå ÀλçÀÌÆ®
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - À¯Åë ä³Î ÇöȲ
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
- ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
- PESTEL ºÐ¼®
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå À¯Åë ä³Î µ¿Çâ
- ¹ë·ùüÀÎ ºÐ¼®
- COVID-19ÀÇ ¿µÇ⠺м®
Á¦5Àå ¼¼°èÀÇ ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, ¾àÁ¦ À¯Çüº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- ´Ü½Ã°£ ÀÛ¿ëÇü
- Àå½Ã°£ ÀÛ¿ëÇü
Á¦6Àå ¼¼°èÀÇ ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, Á¦Çüº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- Á¤Á¦
- ĸ½¶
- ÁÖ»ç
Á¦7Àå ¼¼°èÀÇ ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, À¯Åë ä³Îº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- º´¿ø ¾à±¹
- ¼Ò¸Å ¾à±¹
- ¿Â¶óÀÎ ¾à±¹
Á¦8Àå ¼¼°èÀÇ ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, Áö¿ªº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032³â
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ºÏ¹Ì
- ºÏ¹Ì : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2019-2032³â
- ºÏ¹Ì : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, À¯Åë ä³Îº°, 2019-2032³â
- ºÏ¹Ì : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, Á¦Çüº°, 2019-2032³â
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ¹Ì±¹
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ij³ª´Ù
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - À¯·´
- À¯·´ : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2019-2032³â
- À¯·´ : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, À¯Åë ä³Îº°, 2019-2032
- À¯·´ : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, Á¦Çüº°, 2019-2032³â
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ¿µ±¹
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ÇÁ¶û½º
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - µ¶ÀÏ
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ÀÌÅ»¸®¾Æ
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ½ºÆäÀÎ
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ³×´ú¶õµå
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ·¯½Ã¾Æ
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2019-2032³â
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, À¯Åë ä³Îº°, 2019-2032³â
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, Á¦Çüº°, 2019-2032³â
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - Áß±¹
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - Àεµ
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ¸»·¹À̽þÆ
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ÀϺ»
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - Àεµ³×½Ã¾Æ
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - Çѱ¹
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2019-2032³â
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, À¯Åë ä³Îº°, 2019-2032
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, Á¦Çüº°, 2019-2032³â
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - À̽º¶ó¿¤
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä« : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2019-2032³â
- ¶óƾ¾Æ¸Þ¸®Ä« : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, À¯Åë ä³Îº°, 2019-2032
- ¶óƾ¾Æ¸Þ¸®Ä« : ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå, Á¦Çüº°, 2019-2032³â
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ¸ß½ÃÄÚ
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ºê¶óÁú
- ¿Á½ÃÄÚµ· ÀǾàǰ ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª
Á¦9Àå °æÀï ±¸µµ
- È®Àå ¹× Àμö ºÐ¼®
- Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³
Á¦10Àå ±â¾÷ °³¿ä
- Acura Pharmaceuticals(U.S.)
- Alvogen(U.S.)
- Amneal Pharmaceuticals LLC.(U.S.)
- Ascent Pharmaceuticals, Inc.(U.S.)
- Collegium Pharmaceutical(U.S.)
- Endo International plc(Ireland)
- Epic Pharma, LLC.(U.S.)
- Mallinckrodt(Ireland)
- Mundipharma International(UK)
- Pfizer Inc.(U.S.)
- Protega Pharmaceuticals Inc.(U.S.)
- Rhodes Pharmaceuticals L.P.(U.S.)
- Sun Pharmaceutical Industries Ltd.(India)
LSH
¿µ¹® ¸ñÂ÷
The global oxycodone drugs market size is expected to reach USD 8.29 billion by 2032, according to a new study by Polaris Market Research. The report "Oxycodone Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Short-acting, Long-acting); By Dosage Form; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Rising incidence of chronic pain disease such as cancer, rheumatoid arthritis, lower back pain, and fibromyalgia is the primary contributor for the oxycodone market expansion. Moreover, the unresponsiveness shown by other medications for the treatment of severe pain management has increased the demand for oxycodone drugs. Furthermore, promising results of these drugs and benefits associated with the extended release oxycodone drugs has increased its prescription volumes. Additionally, better compliance and convenience of less-frequent dosage intervals offered by oxycodone drugs will fuel the market growth in the coming years.
The advent of extended-release capsules coupled with the high prevalence of severe pain among adults are also propelling the market growth. Moreover, the patents owned by market players coupled with their increasing expenses on marketing and promotion will contribute to the market growth. For instance, Collegium Pharmaceutical's Xtampza ER has patent protection until 2036.
The promising results shown by the oxycodone drugs over other opioid medications is also driving the market growth. Moreover, the advent of new drugs with advancements in drug delivery systems such as extended-release formulations will provide long-term opportunity for the oxycodone drugs market growth. The ability of oxycodone to lower the severe pain after surgery coupled with an increasing number of surgical procedures are expected to support the market expansion.
The widespread acceptance of oxycodone drugs as a pain-relieving medication and growing need for oxycodone for the pain management after surgeries are the factors propelling the market growth. Moreover, the strong focus of companies on the regulatory approvals in untapped markets will positively influence the market growth. Furthermore, lack of physical activities, tobacco usage, and obesity are increasing the number of patients suffering from chronic pain. For instance, according to the World Obesity Atlas 2023 Report by the World Obesity Federation, the number of people with overweight or obesity worldwide is expected to increase to 4.0 billion, from 2.6 billion in 2020. Such obese people requiring pain management medications will drive the market growth during the forecast period.
Oxycodone Drugs Market Report Highlights
The long-acting segment dominated the market, owing to its benefits for improving pain management and reducing pain intensity variations.
The capsules segment is expected to expand at the highest CAGR, owing to the emergence of extended release capsules.
Hospital segment held the largest market share, owing to the increasing number of surgical procedures and rising hospital admissions.
North America dominated the market, owing to the large volume of oxycodone prescriptions and rising incidences of chronic pain diseases.
The market players include Collegium Pharmaceutical, Mundipharma International, Sun Pharmaceutical Industries Ltd., Endo International plc, and Mallinckrodt.
Polaris Market Research has segmented the oxycodone drugs market report based on drug type, dosage form, distribution channel, and region:
Oxycodone Drugs, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)
Oxycodone Drugs, Dosage Form Outlook (Revenue - USD Billion, 2019 - 2032)
Oxycodone Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Oxycodone Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Oxycodone Drugs Market Insights
- 4.1. Oxycodone Drugs Market - Distribution Channel Snapshot
- 4.2. Oxycodone Drugs Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising incidence of chronic pain is expected to support the oxycodone market expansion
- 4.2.1.2. Increasing expenses for oxycodone drugs will provide a long-term opportunity for the market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Several risks of oxycodone coupled with strict regulations is expected to hamper the market growth
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Oxycodone Drugs Market Distribution Channel Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Oxycodone Drugs Market, by Drug Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 5.3. Short-acting
- 5.3.1. Global Oxycodone Drugs Market, by Short-acting, by Region, 2019-2032 (USD Billion)
- 5.4. Long-acting
- 5.4.1. Global Oxycodone Drugs Market, by Long-acting, by Region, 2019-2032 (USD Billion)
6. Global Oxycodone Drugs Market, by Dosage Form
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 6.3. Tablet
- 6.3.1. Global Oxycodone Drugs Market, by Tablet, by Region, 2019-2032 (USD Billion)
- 6.4. Capsule
- 6.4.1. Global Oxycodone Drugs Market, by Capsule, by Region, 2019-2032 (USD Billion)
- 6.5. Injection
- 6.5.1. Global Oxycodone Drugs Market, by Injection, by Region, 2019-2032 (USD Billion)
7. Global Oxycodone Drugs Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 7.3. Hospital Pharmacy
- 7.3.1. Global Oxycodone Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
- 7.4. Retail Pharmacy
- 7.4.1. Global Oxycodone Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
- 7.5. Online Pharmacy
- 7.5.1. Global Oxycodone Drugs Market, by Online Pharmacy, By Region, 2019-2032 (USD Billion)
8. Global Oxycodone Drugs Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Oxycodone Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Oxycodone Drugs Market - North America
- 8.3.1. North America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.3.2. North America: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.3. North America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.3.4. Oxycodone Drugs Market - U.S.
- 8.3.4.1. U.S.: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.3.5. Oxycodone Drugs Market - Canada
- 8.3.5.1. Canada: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.4. Oxycodone Drugs Market - Europe
- 8.4.1. Europe: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.3. Europe: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.4.4. Oxycodone Drugs Market - UK
- 8.4.4.1. UK: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.4.5. Oxycodone Drugs Market - France
- 8.4.5.1. France: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.5.3. France: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.4.6. Oxycodone Drugs Market - Germany
- 8.4.6.1. Germany: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.4.7. Oxycodone Drugs Market - Italy
- 8.4.7.1. Italy: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.4.8. Oxycodone Drugs Market - Spain
- 8.4.8.1. Spain: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.4.9. Oxycodone Drugs Market - Netherlands
- 8.4.9.1. Netherlands: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.4.10. Oxycodone Drugs Market - Russia
- 8.4.10.1. Russia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.5. Oxycodone Drugs Market - Asia Pacific
- 8.5.1. Asia Pacific: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.5.4. Oxycodone Drugs Market - China
- 8.5.4.1. China: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.4.3. China: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.5.5. Oxycodone Drugs Market - India
- 8.5.5.1. India: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.5.3. India: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.5.6. Oxycodone Drugs Market - Malaysia
- 8.5.6.1. Malaysia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.5.7. Oxycodone Drugs Market - Japan
- 8.5.7.1. Japan: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.5.8. Oxycodone Drugs Market - Indonesia
- 8.5.8.1. Indonesia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.5.9. Oxycodone Drugs Market - South Korea
- 8.5.9.1. South Korea: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.6. Oxycodone Drugs Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.6.4. Oxycodone Drugs Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.6.5. Oxycodone Drugs Market - UAE
- 8.6.5.1. UAE: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.6.6. Oxycodone Drugs Market - Israel
- 8.6.6.1. Israel: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.6.7. Oxycodone Drugs Market - South Africa
- 8.6.7.1. South Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.7. Oxycodone Drugs Market - Latin America
- 8.7.1. Latin America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.7.4. Oxycodone Drugs Market - Mexico
- 8.7.4.1. Mexico: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.7.5. Oxycodone Drugs Market - Brazil
- 8.7.5.1. Brazil: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
- 8.7.6. Oxycodone Drugs Market - Argentina
- 8.7.6.1. Argentina: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Acura Pharmaceuticals (U.S.)
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2.Alvogen (U.S.)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Amneal Pharmaceuticals LLC. (U.S.)
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Ascent Pharmaceuticals, Inc. (U.S.)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Collegium Pharmaceutical (U.S.)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Endo International plc (Ireland)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Epic Pharma, LLC. (U.S.)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Mallinckrodt (Ireland)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Mundipharma International (UK)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Pfizer Inc. (U.S.)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Protega Pharmaceuticals Inc. (U.S.)
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Rhodes Pharmaceuticals L.P. (U.S.)
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Sun Pharmaceutical Industries Ltd. (India)
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
°ü·ÃÀÚ·á